Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay Meeting Abstract

  

Authors:	Batlevi, C.; Rapaport, F.; Intlekofer, A. M.; Reiner, A.; Moskowitz, C. H.; Horwitz, S. M.; Zelenetz, A. D.; Palomba, L.; Moskowitz, A. J.; Gerecitano, J. F.; Hamlin, P. A.; Copeland, A. R.; Matasar, M. J.; Sauter, C. S.; Kumar, A.; Noy, A.; Straus, D. J.; Portlock, C. S.; Criscuolo, F.; He, J.; Royston, D.; Balasubramanian, S.; Reznikovskaya, Y.; Pichardo, J. D.; Stephens, P.; Miller, V.; Levine, R. L.; Seshan, V.; Dogan, A.; Younes, A.
Abstract Title:	Defining the incidence and clinical impact of genomic alterations across different histologic types of lymphoma using a clinically validated comprehensive targeted sequencing assay
Meeting Title:	57th Annual Meeting of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	126
Issue:	23
Meeting Dates:	2015 Dec 5-8
Meeting Location:	Orlando, FL
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2015-12-03
Language:	English
ACCESSION:	WOS:000368020102180
PROVIDER:	wos
DOI:	10.1182/blood.V126.23.2668.2668
Notes:	Meeting Abstract: 2668 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/91499